{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T19:13:30Z","timestamp":1722626010171},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s12325-017-0510-2","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T14:02:48Z","timestamp":1489413768000},"page":"966-974","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Value and Evaluability of the PCA3 Urine Assay in Prostate Carcinoma is Independent of the Tumor Localization"],"prefix":"10.1007","volume":"34","author":[{"given":"Eva","family":"Neumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Hennenlotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Todenh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Scharpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Bedke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"issue":"23","key":"510_CR1","first-page":"5975","volume":"59","author":"MJ Bussemakers","year":"1999","unstructured":"Bussemakers MJ, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999;59(23):5975\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"510_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","volume":"44","author":"D Hessels","year":"2003","unstructured":"Hessels D, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44(1):8\u201315 (discussion 15\u20136).","journal-title":"Eur Urol"},{"issue":"9","key":"510_CR3","first-page":"2695","volume":"62","author":"JB Kok de","year":"2002","unstructured":"de Kok JB, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62(9):2695\u20138.","journal-title":"Cancer Res"},{"issue":"5","key":"510_CR4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1586\/14737159.7.5.491","volume":"7","author":"A Taille de la","year":"2007","unstructured":"de la Taille A. Progensa PCA3 test for prostate cancer detection. Expert Rev Mol Diagn. 2007;7(5):491\u20137.","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"510_CR5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1464-410X.2009.09085.x","volume":"105","author":"D Schilling","year":"2010","unstructured":"Schilling D, et al. The prostate cancer gene 3 assay: indications for use in clinical practice. BJU Int. 2010;105(4):452\u20135.","journal-title":"BJU Int"},{"key":"510_CR6","unstructured":"Mottet NBJ, Briers E, van den Bergh RCN, Bolla M, van Casteren NJ, Cornford P, Culine S, Joniau S, Lam T, Mason MD, Matveev V, van der Poel H, van der Kwast TH, Rouviere O, Wiegel T. Guidelines on prostate cancer. 2016. https:\/\/uroweb.org\/guideline\/prostate-cancer\/ . Accessed 15 Jan 2017."},{"issue":"6","key":"510_CR7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0022-5347(17)42876-X","volume":"139","author":"TA Stamey","year":"1988","unstructured":"Stamey TA, et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol. 1988;139(6):1235\u201341.","journal-title":"J Urol"},{"issue":"5","key":"510_CR8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","volume":"179","author":"H Nakanishi","year":"2008","unstructured":"Nakanishi H, et al. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. J Urol. 2008;179(5):1804\u20139 (discussion 1809\u201310).","journal-title":"J Urol"},{"issue":"6","key":"510_CR9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1464-410X.2003.04140.x","volume":"91","author":"H Augustin","year":"2003","unstructured":"Augustin H, et al. Differences in biopsy features between prostate cancers located in the transition and peripheral zone. BJU Int. 2003;91(6):477\u201381.","journal-title":"BJU Int"},{"issue":"5","key":"510_CR10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.urology.2012.08.012","volume":"80","author":"V Iremashvili","year":"2012","unstructured":"Iremashvili V, et al. Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy. Urology. 2012;80(5):1063\u20139.","journal-title":"Urology"},{"issue":"4","key":"510_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/pcan.2013.32","volume":"16","author":"MM Padilha","year":"2013","unstructured":"Padilha MM, et al. Prediction of prostate cancer to urethra distance by a pretreatment nomogram: urethral thermoprotection implication in cryoablation. Prostate Cancer Prostatic Dis. 2013;16(4):372\u20135.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"510_CR12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.juro.2010.11.072","volume":"185","author":"V Vlaeminck-Guillem","year":"2011","unstructured":"Vlaeminck-Guillem V, et al. Urinary PCA3 score predicts prostate cancer multifocality. J Urol. 2011;185(4):1234\u20139.","journal-title":"J Urol"},{"issue":"6","key":"510_CR13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.humpath.2010.02.011","volume":"41","author":"M Andreoiu","year":"2010","unstructured":"Andreoiu M, Cheng L. Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol. 2010;41(6):781\u201393.","journal-title":"Hum Pathol"},{"issue":"3","key":"510_CR14","first-page":"209","volume":"52","author":"SE Delacroix","year":"2010","unstructured":"Delacroix SE, Ward JF. Prostate cancer multifocality: impact on cancer biology and treatment recommendations. Panminerva Med. 2010;52(3):209\u201316.","journal-title":"Panminerva Med"},{"issue":"1","key":"510_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.21032","volume":"70","author":"D Hessels","year":"2010","unstructured":"Hessels D, et al. Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer. Prostate. 2010;70(1):10\u20136.","journal-title":"Prostate"},{"issue":"5","key":"510_CR16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","volume":"54","author":"A Haese","year":"2008","unstructured":"Haese A, et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol. 2008;54(5):1081\u20138.","journal-title":"Eur Urol"},{"issue":"11","key":"510_CR17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/pros.20781","volume":"68","author":"MP Gils van","year":"2008","unstructured":"van Gils MP, et al. Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results. Prostate. 2008;68(11):1215\u201322.","journal-title":"Prostate"},{"issue":"5","key":"510_CR18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2011.08.003","volume":"60","author":"M Auprich","year":"2011","unstructured":"Auprich M, et al. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. Eur Urol. 2011;60(5):1045\u201354.","journal-title":"Eur Urol"},{"issue":"3","key":"510_CR19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2010.11.044","volume":"59","author":"G Ploussard","year":"2011","unstructured":"Ploussard G, et al. Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance. Eur Urol. 2011;59(3):422\u20139.","journal-title":"Eur Urol"},{"issue":"10","key":"510_CR20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00000478-200310000-00001","volume":"27","author":"ME Chen","year":"2003","unstructured":"Chen ME, et al. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol. 2003;27(10):1291\u2013301.","journal-title":"Am J Surg Pathol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0510-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-017-0510-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0510-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:25:04Z","timestamp":1568913904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-017-0510-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1007\/s12325-017-0510-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}